Tridopa Tablet 100 mg+25 mg+200 mg is a combination therapy containing Levodopa, Carbidopa, and Entacapone, designed for the effective management of Parkinson’s disease. This formulation provides higher doses of Levodopa and Carbidopa, offering stronger symptom control for patients with advanced Parkinsonism or significant motor fluctuations.
-
Levodopa replenishes dopamine in the brain, alleviating motor symptoms such as tremor, rigidity, and bradykinesia.
-
Carbidopa inhibits peripheral metabolism of Levodopa, reducing gastrointestinal side effects and ensuring more reaches the CNS.
-
Entacapone is a COMT inhibitor that prolongs the action of Levodopa, minimizing “off” periods and improving daily mobility.
This combination allows for enhanced symptom control, reducing motor complications and improving quality of life.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Indications
Tridopa Tablet 100 mg+25 mg+200 mg is indicated for:
-
Idiopathic Parkinson’s disease, particularly in advanced stages
-
Patients experiencing “wearing-off” phenomenon with lower doses of Levodopa
-
Management of tremors, rigidity, bradykinesia, and postural instability
-
Adjunct therapy to optimize dopaminergic treatment for better motor control
Mechanism of Action
The three components of Tridopa work synergistically:
-
Levodopa: Crosses the blood-brain barrier and converts to dopamine, compensating for deficient neurotransmitter levels.
-
Carbidopa: Prevents peripheral decarboxylation of Levodopa, enhancing CNS availability and reducing nausea.
-
Entacapone: Inhibits COMT, slowing the breakdown of Levodopa, stabilizing blood levels, and reducing “off” periods.
This combination ensures prolonged and consistent dopaminergic activity for improved motor function.
Dosage and Administration
-
Recommended dose: 1 tablet (100 mg Levodopa + 25 mg Carbidopa + 200 mg Entacapone) at prescribed intervals, typically 3–4 times daily based on clinical response
-
Take with or immediately after meals to reduce gastrointestinal discomfort
-
Do not crush or chew the tablet
-
Gradual dose adjustments may be needed in renal or hepatic impairment
-
Follow your physician’s instructions closely to optimize symptom control
Benefits
-
Reduces motor fluctuations and “off” episodes
-
Controls tremors, rigidity, and bradykinesia effectively
-
Improves mobility, balance, and daily activity performance
-
Provides prolonged Levodopa action with reduced dosing frequency
-
Enhances overall quality of life in advanced Parkinson’s disease
Side Effects
Common side effects may include:
-
Nausea, vomiting, or loss of appetite
-
Dizziness or orthostatic hypotension
-
Dyskinesia (involuntary movements)
-
Sleep disturbances or vivid dreams
Serious but rare side effects:
-
Severe psychiatric symptoms (hallucinations, confusion, psychosis)
-
Neuroleptic malignant-like syndrome (muscle rigidity, high fever)
-
Severe cardiovascular effects (arrhythmia, hypotension)
Seek immediate medical attention if severe psychiatric, neurological, or cardiovascular symptoms occur.
Precautions and Warnings
-
Use cautiously in patients with cardiovascular disease, psychiatric disorders, or hepatic/renal impairment
-
Monitor for impulse control disorders such as gambling or hypersexuality
-
Avoid abrupt discontinuation
-
Regular follow-up is essential to adjust dosage and monitor side effects
-
Pregnancy and breastfeeding: only use if clearly needed under medical supervision
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Drug Interactions
Tridopa may interact with:
-
MAO inhibitors (risk of hypertensive crisis)
-
Antipsychotic drugs (may reduce Levodopa effectiveness)
-
Dopamine agonists or other Parkinson’s medications (dose adjustments may be required)
-
Medications affecting liver or kidney function
Always inform your healthcare provider about all medications and supplements before starting therapy.
Storage
-
Store below 25°C in a dry, cool place
-
Protect from light and moisture
-
Keep out of reach of children
-
Do not use after the expiration date.